MISONIX, Inc. (MSON): Price and Financial Metrics
GET POWR RATINGS... FREE!
MSON Stock Price Chart Interactive Chart >
MSON Price/Volume Stats
|Current price||$26.54||52-week high||$26.99|
|Prev. close||$25.34||52-week low||$11.04|
|Day high||$26.56||Avg. volume||60,302|
|50-day MA||$25.60||Dividend yield||N/A|
|200-day MA||$21.45||Market Cap||462.06M|
MISONIX, Inc. (MSON) Company Bio
Misonix, Inc. produces and distributes medical devices. The Company offers devices for spinal decompression, wound management, tumor removal, and general surgery. Misonix markets its products in the United States.
Most Popular Stories View All
MSON Latest News Stream
|Loading, please wait...|
MSON Latest Social Stream
View Full MSON Social Stream
Latest MSON News From Around the Web
Below are the latest news stories about Misonix Inc that investors may wish to consider to help them evaluate MSON as an investment opportunity.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes, today announced that the stockholders of Bioventus approved the issuance of shares of Bioventus class A common stock to the stockholders of Mison
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (Misonix), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the Election Deadline) for stockholders of Misonix to elect the form of consideration they wish to receive for their shares of Misonix common stock in connection with the proposed merger of Oyster Merger Sub I, Inc., a newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub I), with and into Misonix, immediately followed by the merger of Misonix with and into Oyster Merger Sub II, LLC, another newly-formed, wholly-owned subsidiary of Bioventus (Merger Sub II), pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated as of July 29,...
Radiofrequency Ablation System Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2021 – 2027 | Ethicon, Arthrex GmbH, Johnson & Johnson, Misonix, SonaCare Medical, Integra LifeSciences Corporat
The “Radiofrequency Ablation System Market” provides analysis and insights relating to the many factors expected to be rife throughout the forecast amount whereas providing their impacts on the Market’s growth. The increase within the aviation sector is escalating the expansion
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, EBMT, MSON, NLOK; Shareholders are Encouraged to Contact the Firm
NEW YORK, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Hill-Rom Holdings, Inc. (NYSE: HRC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Baxter International Inc. for $156.00 per share in cash. If you are a Hill-Rom shareholder, click here to learn more about your rights and options. Eagle Bancorp Montana, Inc. (NASDAQ: EBMT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MSON, RIVE, OSBC, IRT, ISBC; Shareholders are Encouraged to Contact the Firm
NEW YORK , Oct. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Misonix, Inc. (NASDAQ: MSON ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bioventus Inc. Under the terms of the agreement, Misonix stockholders may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration. If you are a Misonix shareholder, click here to learn more about your rights and options . Full story available on Benzinga.com
MSON Price Returns